Gene Symbol | Pearson Correlation Coefficient |
---|---|
SLC25A18 | 0.63 |
NWD1 | 0.587 |
LFNG | 0.583 |
MT1F | 0.576 |
GRTP1 | 0.567 |
SMOX | 0.566 |
PHYHD1 | 0.561 |
RLBP1 | 0.56 |
SLC39A12 | 0.557 |
MT1E | 0.556 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
TC2N | -0.489 |
CLVS1 | -0.433 |
AFP | -0.412 |
ARHGAP20 | -0.41 |
KCNT2 | -0.409 |
ARNTL2 | -0.407 |
TXK | -0.4 |
L3MBTL3 | -0.396 |
TRAF5 | -0.394 |
NPY5R | -0.392 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB01593 | Zinc | Small Molecule | 7440-66-6 | Approved|Investigational | Target |
DB09130 | Copper | Small Molecule | 7440-50-8 | Approved|Investigational | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of HPR protein | 20106945 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of HPR mRNA | 21641981|2715375 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of HPR gene | 27153756 |
D001379 | Azathioprine | Azathioprine results in decreased expression of HPR mRNA | 22623647 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of HPR mRNA | 21632981 |
D002104 | Cadmium | HPR protein binds to Cadmium | 23896426 |
D003300 | Copper | HPR protein binds to Copper | 23896426 |
D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of HPR mRNA | 19549813 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of HPR mRNA | 20106945|2798913 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of HPR mRNA | 25047013 |
C000944 | dicrotophos | dicrotophos results in decreased expression of HPR mRNA | 28302478 |
D008727 | Methotrexate | Methotrexate results in decreased expression of HPR mRNA | 24449571 |
D009532 | Nickel | HPR protein binds to Nickel | 23896426 |
C046012 | pentanal | pentanal results in decreased expression of HPR mRNA | 26079696 |
C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HPR mRNA | 19710929 |
D011794 | Quercetin | Quercetin results in decreased expression of HPR mRNA | 21632981 |
C016766 | sulforafan | sulforafan results in increased expression of HPR mRNA | 26833863 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of HPR mRNA | 20106945|2163298 |
D014520 | Urethane | Urethane results in decreased expression of HPR mRNA | 28818685 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of HPR mRNA | 29154799 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of HPR gene | 29154799 |
D015032 | Zinc | HPR protein binds to Zinc | 23896426 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004252 | serine-type endopeptidase activity | - | IBA | 21873635 |
GO:0030492 | hemoglobin binding | - | NAS | 2987228 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0002526 | acute inflammatory response | - | IBA | 21873635 |
GO:0006898 | receptor-mediated endocytosis | - | TAS | - |
GO:0010033 | response to organic substance | - | IBA | 21873635 |
GO:0010942 | positive regulation of cell death | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005576 | extracellular region | - | TAS | - |
GO:0005615 | extracellular space | - | IBA | 21873635 |
GO:0034366 | spherical high-density lipoprotein particle | - | IDA | 16682745 |
GO:0070062 | extracellular exosome | - | HDA | 23533145 |
GO:0072562 | blood microparticle | - | HDA | 22516433 |
KEGG ID | KEGG Term |
---|---|
hsa05143 | African trypanosomiasis |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-2168880 | Scavenging of heme from plasma | TAS |
R-HSA-2173782 | Binding and Uptake of Ligands by Scavenger Receptors | TAS |
R-HSA-5653656 | Vesicle-mediated transport | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
26247099 | Predictors of high on-clopidogrel platelet reactivity in patients with acute coronary syndrome. (2016) | Lee S | Platelets |
15756035 | Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer. (2005 Mar 1) | Serrano D | Clin Cancer Res |
22440495 | Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study. (2012 Mar) | Ueno M | JACC Cardiovasc Interv |
23651444 | Factors affecting residual platelet aggregation in prasugrel treated patients. (2013) | Alexopoulos D | Curr Pharm Des |
22507978 | Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study. (2012 Sep) | Park Y | Eur Heart J |
28877606 | Discordance Between VASP Phosphorylation and Platelet Aggregation in Defining High On-Clopidogrel Platelet Reactivity After ST-Segment Elevation Myocardial Infarction. (2018 Jan) | Sun J | Clin Appl Thromb Hemost |
25860557 | Correlation Between SNPs in Candidate Genes and VerifyNow-Detected Platelet Responsiveness to Aspirin and Clopidogrel Treatment. (2015 Apr) | Cui H | Cardiovasc Drugs Ther |
23602770 | The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. (2013 Aug 6) | Gurbel PA | J Am Coll Cardiol |